Products
- Anti-Obesity Compound Library
- GPCR/G Protein-Targeted Compounds
- Immunology/Inflammation-Targeted Compounds
- JAK/STAT-Targeted Compounds
- MAPK-Targeted Compounds
- Membrane Transporter/Ion Channel-Targeted Compounds
- Metabolism-Targeted Compounds
- NF-κB-Targeted Compounds
- Microbiology/Virology-Targeted Compounds
- Neuronal Signaling-Targeted Compounds
- PI3K/Akt/mTOR-Targeted Compounds
- Oxidation-reduction-Targeted Compounds
- Proteases/Proteasome-Targeted Compounds
- Stem Cells/Wnt-Targeted Compounds
- Tyrosine Kinase/Adaptors-Targeted Compounds
- Ubiquitin-Targeted Compounds
Online Inquiry
Nordihydroguaiaretic acid
Cat. No.:
OB0225LY-0338
Appearance:
Solid
Purity:
≥99%
Identity:
Confirmed by NMR and HPLC.
Size:
Add to basket
Product Overview
Description:
Nordihydroguaiaretic acid is a natural phenolic compound with antioxidant and anti-inflammatory properties.
Synonym:
NDGA; Dihydronorguaiaretic acid; 500-38-9; 4-[4-(3,4-Dihydroxyphenyl)-2,3-dimethylbutyl]benzene-1,2-diol; 1,2-Benzenediol, 4,4'-(2,3-dimethyl-1,4-butanediyl)bis-; 4,4'-(2,3-Dimethyltetramethylene)dipyrocatechol; 2,3-Bis(3,4-dihydroxyphenylmethyl)butane
CAS No.:
500-38-9
Compound CID:
4534
Formula:
C18H22O4
Formula Weight:
302.36
Specification
Relative Density:
1.0772 g/cm3
Stability:
3 years in powder form.
Storage:
Storage at -20°C.
Applications:
Nordihydroguaiaretic acid can be used in the study of antioxidant mechanisms, or play an important role in the study of inflammatory response.
Library Information
Targets:
Lipoxygenase
Pathways:
Apoptosis; Metabolism; Autophagy; Oxidation-reduction
Plate Number:
AOCL-5
Plate Location:
d2
Empty Location:
a1-h1; a12-h12
Container:
96-well plate
Formulation:
10 mM DMSO
DMSO Max Solubility:
43 mg/mL
Solubility:
10% DMSO+90% Saline: 4.3 mg/mL (14.22 mM)
ALogP:
4.708
HBA_Count:
0
HBD_Count:
4
Rotatable Bond:
5
